SCHEMBL23985252

SCHEMBL23985252

Nc1cccc2c1C(O)NC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.39
ADORA2A P29274 2/20 0.36
PTPRC P08575 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
RGS12 O14924 1/20 0.36
USP2 O75604 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
CYP2C9 P11712 1/20 0.36
APEX1 P27695 1/20 0.36
CASP1 P29466 1/20 0.36
BRCA1 P38398 1/20 0.36
MTOR P42345 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1081094 0.78 PBRM1 (0.49) KMT2AMEN1RECQLPRKD3PRKCG
SCHEMBL26801767 0.78 TSHR (0.40) PARP1ADORA2APTPRCKMT2AMEN1
SCHEMBL11358351 0.78 PBRM1 (0.49) PARP1KMT2AMEN1MAPTNPSR1
SCHEMBL10049028 0.75 PRKD3 (0.34) PARP1KMT2AHSD17B10PRKD3PRKCG
SCHEMBL23985251 0.74 PARP1 (0.36) PARP1ADORA2APTPRCKMT2AMEN1
SCHEMBL9910771 0.74 TTR (0.35) PARP1KMT2AMAPTHSD17B10PRKD3
SCHEMBL23797113 0.73 S100A4 (0.46) PTPRCKMT2AMEN1POLBMAPT
SCHEMBL21903887 0.73 S100A4 (0.46) PTPRCKMT2AMEN1POLBMAPT
SCHEMBL23985895 0.70 PARP1 (0.38) PARP1KMT2AMEN1RGS12USP2
SCHEMBL21788595 0.69 HTR2C (0.43) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230353959-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2023-11-02 US disclosed
US-20230353959-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2023-11-02 US disclosed
EP-4143196-A1 PI3K-a INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2023-03-08 EP disclosed
WO-2021222556-A1 PI3K-α INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed